Literature DB >> 2828401

Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology.

J M Crance1, J Passagot, E Biziagos, R Deloince.   

Abstract

The strain CF53 of hepatitis A virus (HAV) previously adapted to growth in PLC/PRF/5 cells was grown in 175 cm2 flasks, at different passages. After infection, cells were incubated at 32 degrees C in RPMI 1640 medium supplemented with 2.5% foetal calf serum (FCS) for 6-12 months. HAV which was released continuously in the culture medium was harvested weekly. Hepatitis A virus antigen (HAAg) and infectious virus production was stable during each passage. The antigen titre, determined by radioimmunoassay, was about 50 for each passage whereas the infectious virus titre increased from 10(3.7) (passage 7) to 10(6.0) TCID50/ml (passage 13). Virus production was not influenced by the FCS concentration (0-2.5%) in the maintenance medium. The cell culture produced HAAg was used for detection of total anti-HAV antibodies, anti-HAV titration and IgM antibody capture assay and the results were identical to those obtained with commercial kits. HAAg produced by this practical and cheap method could easily replace primate derived antigen for the detection of anti-HAV antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2828401     DOI: 10.1016/0166-0934(87)90124-8

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Long-term survival of hepatitis A virus and poliovirus type 1 in mineral water.

Authors:  E Biziagos; J Passagot; J M Crance; R Deloince
Journal:  Appl Environ Microbiol       Date:  1988-11       Impact factor: 4.792

2.  Detection of hepatitis A virus, rotavirus, and enterovirus in naturally contaminated shellfish and sediment by reverse transcription-seminested PCR.

Authors:  F Le Guyader; E Dubois; D Menard; M Pommepuy
Journal:  Appl Environ Microbiol       Date:  1994-10       Impact factor: 4.792

3.  Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen.

Authors:  D Crevat; J M Crance; A M Chevrinais; J Passagot; E Biziagos; G Somme; R Deloince
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Inhibitory effects of atropine, protamine, and their combination on hepatitis A virus replication in PLC/PRF/5 cells.

Authors:  E Biziagos; J M Crance; J Passagot; R Deloince
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 5.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.